Capabilities for Partners

Rational design of bioactive compounds: preparation and filtering of chemical libraries, virtual screening, molecular docking, pharmacophore modelling and machine-learning approaches.

Hit-to-Lead and Lead Optimization: prioritization of molecules by binding affinity, selectivity, chemical diversity, availability and physicochemical properties, followed by selection of a focused set of compounds for experimental testing.

We develop synthetic routes and prepare specialized, rare or commercially unavailable chemical compounds to the partner’s specifications. Our work includes optimization of reaction conditions, purification and structural confirmation of the products. Each synthesized compound is supplied with a certificate of analysis, purity data and results from the relevant quality-control methods.

We provide access to a collection of synthesized small molecules for primary biological screening against a broad range of molecular targets.

The collection supports the discovery of compounds with potential antibacterial, antifungal and anticancer activity for further investigation.

Comprehensive characterization of medicinal plant materials and extracts, including chemical profiling, identification of active constituents, standardization and formulation development based on natural compounds. Artificial intelligence is used to predict biological activity and identify the most promising combinations of plant-derived constituents.